122 related articles for article (PubMed ID: 37742832)
1. Breast Irradiation Is Well Tolerated in Carriers of a Pathogenic ATM Variant.
Zureick AH; Zakalik D; Quinn TJ; Rangarajan TS; Grzywacz VP; Rotenbakh LR; Chen PY; Dilworth JT
Pract Radiat Oncol; 2024; 14(1):e29-e39. PubMed ID: 37742832
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of Breast Radiotherapy Among Carriers of
Modlin LA; Flynn J; Zhang Z; Cahlon O; Mueller B; Khan AJ; Gillespie EF; McCormick B; Stadler ZK; Robson ME; Powell SN; Braunstein LZ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250389
[TBL] [Abstract][Full Text] [Related]
3. ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.
McDuff SGR; Bellon JR; Shannon KM; Gadd MA; Dunn S; Rosenstein BS; Ho AY
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1373-1382. PubMed ID: 33545302
[TBL] [Abstract][Full Text] [Related]
4. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
Iannuzzi CM; Atencio DP; Green S; Stock RG; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):606-13. PubMed ID: 11849780
[TBL] [Abstract][Full Text] [Related]
5. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
[TBL] [Abstract][Full Text] [Related]
6. Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.
Bergom C; Kelly T; Morrow N; Wilson JF; Walker A; Xiang Q; Ahn KW; White J
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):821-8. PubMed ID: 22208973
[TBL] [Abstract][Full Text] [Related]
7. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
[TBL] [Abstract][Full Text] [Related]
8. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK
Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223
[TBL] [Abstract][Full Text] [Related]
9. Ataxia-telangiectasia gene (
Jerzak KJ; Mancuso T; Eisen A
Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
[TBL] [Abstract][Full Text] [Related]
10. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
Cragun D; Weidner A; Tezak A; Clouse K; Pal T
Breast Cancer Res Treat; 2020 Jul; 182(2):421-428. PubMed ID: 32445176
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Yang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Zhang J; Xie Y
Breast Cancer Res Treat; 2019 Apr; 174(3):639-647. PubMed ID: 30607632
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
Yadav BS; Sharma SC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
[TBL] [Abstract][Full Text] [Related]
14. Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
Petrackova A; Savara J; Turcsanyi P; Gajdos P; Papajik T; Kriegova E
Br J Haematol; 2022 Nov; 199(3):371-381. PubMed ID: 36029002
[TBL] [Abstract][Full Text] [Related]
15. Increased radiation toxicity with germline ATM variant of uncertain clinical significance.
Mullins BT; Gupta G
Rep Pract Oncol Radiother; 2019; 24(6):672-680. PubMed ID: 31719806
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
Pitter KL; Casey DL; Lu YC; Hannum M; Zhang Z; Song X; Pecorari I; McMillan B; Ma J; Samstein RM; Pei IX; Khan AJ; Braunstein LZ; Morris LGT; Barker CA; Rimner A; Alektiar KM; Romesser PB; Crane CH; Yahalom J; Zelefsky MJ; Scher HI; Bernstein JL; Mandelker DL; Weigelt B; Reis-Filho JS; Lee NY; Powell SN; Chan TA; Riaz N; Setton J
J Natl Cancer Inst; 2021 Mar; 113(3):266-273. PubMed ID: 32726432
[TBL] [Abstract][Full Text] [Related]
17. Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.
Chapman BV; Liu D; Shen Y; Olamigoke OO; Lakomy DS; Barrera AMG; Stecklein SR; Sawakuchi GO; Bright SJ; Bedrosian I; Litton JK; Smith BD; Woodward WA; Perkins GH; Hoffman KE; Stauder MC; Strom EA; Arun BK; Shaitelman SF
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):437-444. PubMed ID: 34582940
[TBL] [Abstract][Full Text] [Related]
18. Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM.
Renault AL; Dowty JG; Steen JA; Li S; Winship IM; Giles GG; Hopper JL; Southey MC; Nguyen-Dumont T
Breast Cancer Res; 2022 Apr; 24(1):24. PubMed ID: 35365198
[TBL] [Abstract][Full Text] [Related]
19. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects.
Bremer M; Klöpper K; Yamini P; Bendix-Waltes R; Dörk T; Karstens JH
Radiother Oncol; 2003 Nov; 69(2):155-60. PubMed ID: 14643952
[TBL] [Abstract][Full Text] [Related]
20. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.
Ho AY; Fan G; Atencio DP; Green S; Formenti SC; Haffty BG; Iyengar P; Bernstein JL; Stock RG; Cesaretti JA; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):677-84. PubMed ID: 17517479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
